Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53.4M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
15.9M
-
Shares change
-
-213K
-
Total reported value, excl. options
-
$90.1M
-
Value change
-
-$1.16M
-
Number of buys
-
11
-
Number of sells
-
-11
-
Price
-
$5.68
Significant Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q1 2022
35 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock as of Q1 2022.
scPharmaceuticals Inc. - Common Stock (SCPH) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.9M shares
of 53.4M outstanding shares and own 29.76% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (4.8M shares), 5AM Venture Management, LLC (3.83M shares), RA CAPITAL MANAGEMENT, L.P. (2.66M shares), AIGH Capital Management LLC (1.4M shares), Ikarian Capital, LLC (970K shares), VANGUARD GROUP INC (617K shares), Worth Venture Partners, LLC (348K shares), RENAISSANCE TECHNOLOGIES LLC (186K shares), Belvedere Trading LLC (161K shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (132K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.